Venastat Horse Chestnut Extract

by AJG Brands · capsule · 60 capsules

  • On the market (NIH)
  • DSLD label 12902
  • Serving 1 capsule; amounts per 2 capsules

Venastat Horse Chestnut Extract by AJG Brands lists one ingredient: 600 mg of horse chestnut HC167(R) extract seed per serving of 2 capsules. Its current label entered the NIH Dietary Supplement Label Database on October 1, 2012.

What is in Venastat Horse Chestnut Extract?

Each row as the label prints it, per serving of 2 capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Venastat Horse Chestnut Extract: Supplement Facts rows against the market (DSLD label 12902, January 2026 release)
IngredientAmount% DVAmong products listing it
Horse Chestnut HC167(R) Extract Seedas Standardized to contain 16.7% Escin600 mgHorse Chestnut in Venastat Horse Chestnut Extract against 183 products600 mg per serving; the middle half of products list 100 mg to 300 mg, the median 250 mg.600 mg

Higher than 92% of 183 products listing horse chestnut (median 250 mg). Per day at the most servings: 1,200 mg.

Source: NIH ODS Dietary Supplement Label Database, label 12902 (entered October 1, 2012), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

The rows in the top or bottom tenth of the products that list the same ingredient, and any above the adult upper limit at the most servings a day the directions give:

  • Its 600 mg of horse chestnut is higher than 92% of the 183 horse chestnut products that print an amount; 8 list more.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Recommended Intake Adults should take one capsule every 12 hours (2 per day 600mg per daily serving). It should be taken swallowed with water before meals. Clinical research has shown effectiveness in as early as four weeks with continuous, daily use.

Source: label statements in DSLD label 12902.

What else is on the label?

Other ingredients: Natural organic sugar can extract, Dextrin, Gelatin, Copolyvidone, Talc, Food Glaze, polymethacrylic acid derivatives, Titanium Dioxide, synthetic iron oxides.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): Quality Guarantee.

How many labels does Venastat Horse Chestnut Extract have?

One label is on file, entered on October 1, 2012.

  1. Label 12902 (current) Entered October 1, 2012 · on the market · 60 capsules

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names AJG Brands, Inc., Alan James Group (manufacturer). All AJG Brands products.

Where next?